Gufic Biosciences Limited Teicoplanin Export Data — India (DGFT 2022–2026)

Name: Gufic Biosciences Limited Teicoplanin Export Records India — #1 Exporter, 87 Shipments, $4.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Teicoplanin

India Pharmaceutical Trade Intelligence

$6.3M60 Suppliers44 CountriesHS 30042099

ExportsIndia → HUNGARY35.6%India → SRI LANKA18.4%

ImportsITALY → India$65.9B FRANCE → India$517.3K

#1 Supplier: GUFIC BIOSCIENCES

Gufic Biosciences Limited — Teicoplanin Exporter #1 | $4.3M Trade Value | TransData Nexus | TransData Nexus

Gufic Biosciences Limited — Teicoplanin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Teicoplanin · $4.3M export value · DGFT Verified

Gufic Biosciences Limited is the #1 Indian exporter of Teicoplanin with $4.3M in export value and 87 verified shipments. Gufic Biosciences Limited holds a 69.2% market share in Teicoplanin exports across 8 countries. The company exports 5 pharmaceutical products worth $12.6M across 4 therapeutic categories.

Gufic Biosciences Limited — Teicoplanin Export Profile: Buyers & Destinations

Gufic Biosciences Limited Teicoplanin export treemap — buyers and destination countries | TransData Nexus

Where Does Gufic Biosciences Limited Export Teicoplanin?

Country	Value	Shipments	Share
SRI LANKA	$749.2K	30	40.3%
HUNGARY	$506.7K	23	27.2%
SOUTH AFRICA	$316.4K	10	17.0%
GERMANY	$175.6K	7

Who Are the Top Buyers of Teicoplanin from Gufic Biosciences Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	SRI LANKA	$623.7K	36
SLIM PHARMACEUTICALS (PVT) LTD,	SRI LANKA	$239.1K	14
AUSTELL PHARMACEUTICALS (PTY) LTD,	SOUTH AFRICA	$133.0K	4
HANSE SERVICE INTERNATIONALE	GERMANY	$131.2K	3
HATTON NATIONAL BANK PLC,	SRI LANKA	$110.5K	3
PEOPLE'S BANK,	SRI LANKA	$100.0K	2
BANK OF CEYLON	SRI LANKA	$94.5K	4
AUSTELL PHARMACEUTICALS ( PTY) LTD	SOUTH AFRICA	$67.3K	3
AUSTELL PHARMACEUTICALS ( PTY) LIMITED	SOUTH AFRICA	$66.1K	2
SLIM PHARMACEUTICALS PVT LTD	SRI LANKA	$50.0K	1

Gufic Biosciences Limited supplies Teicoplanin to 19 buyers globally. The largest buyer is TO THE ORDER OF (SRI LANKA), followed by SLIM PHARMACEUTICALS (PVT) LTD, (SRI LANKA) and AUSTELL PHARMACEUTICALS (PTY) LTD, (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Teicoplanin Formulations Does Gufic Biosciences Limited Export?

Product Description / Formulation	Value	Shipments
TICPLAT 200 INJ (TEICOPLANIN FOR INJ 200	$110.5K	3
TEGORID IV 400 (TEICOPLANIN 400 mg INJ)	$100.0K	2
TICPLAT 400 INJ (TEICOPLANIN FOR INJ 400	$100.0K	2
TICPLAT 400(TEICOPLANIN FOR INJ 400 mg)	$99.8K	6
TICPLAT 200 INJ TEICOPLANIN FOR INJ 200MG 28110 VIALS	$50.0K	1
TEICOPLANIN EBERTH 400 MG PACK SIZE 1X1 S VLS 24000 VLS	$50.0K	1
TICPLAT 400 (TEICOPLANIN FOR INJ 400 MG)(8000 VIALS)	$50.0K	1
TICPLAT 200 (TEICOPLANIN FOR INJ 200 MG)(20000 VIALS)	$50.0K	1
TICPLAT 200 INJ (TEICOPLANIN 200 mg POWDER FOR SOLUTION FOR INJECTION INFUSION)(15216 VIALS)	$50.0K	1
TEICOPLANIN FOR INJECTION 400 MG (TEGORID IV 400 ), 64420 VIALS, PACK SIZE- ( 1X1'S )	$50.0K	1

Gufic Biosciences Limited exports 68 distinct Teicoplanin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TICPLAT 200 INJ (TEICOPLANIN FOR INJ 200 with 3 shipments worth $110.5K.

How Does Gufic Biosciences Limited Compare to Nearest Teicoplanin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GUFIC BIOSCIENCES LIMITED ★	$4.3M	87	8	$50.0K
2	FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED	$250.0K	5	3	$50.0K
3	JODAS EXPOIM PRIVATE LIMITED	$250.0K	5	1	$50.0K

Gufic Biosciences Limited ranks #1 among 60 Indian Teicoplanin exporters. Average shipment value of $50.0K compared to the market average of $95.7K. The closest competitors by value are FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED and JODAS EXPOIM PRIVATE LIMITED.

Which Indian Ports Ship Teicoplanin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	69	22.3%
SAHAR AIR	67	21.6%
NHAVA SHEVA SEA (INNSA1)	27	8.7%
DELHI AIR	24	7.7%
Bombay Air	22	7.1%
DELHI AIR CARGO ACC (INDEL4)	16	5.2%
CHENNAI AIR CARGO ACC (INMAA4)	8	2.6%
HYDERABAD AIR	8	2.6%

Geopolitical & Trade Policy Impact on Gufic Biosciences Limited's Teicoplanin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Gufic Biosciences. The Israel-Iran conflict has led to increased tensions in the Red Sea, a vital shipping route for Indian exports. Houthi attacks in the region have disrupted maritime logistics, resulting in higher shipping costs and potential delays. These disruptions could impact Gufic's supply chain efficiency and delivery timelines, necessitating strategic adjustments to maintain export commitments.

In the United States, recent tariff policies have introduced uncertainties for pharmaceutical imports. While health products have been exempt from tariffs, there have been threats to impose significant increases to encourage domestic production. Such measures could affect Indian exporters, including Gufic, by altering the competitive landscape and potentially reducing market share in the U.S. (lemonde.fr)

Conversely, U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to fill gaps left by Chinese suppliers. Gufic could leverage this opportunity to expand its footprint in markets seeking alternative sources for pharmaceutical products.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The directive mandates stringent serialization and traceability measures to prevent counterfeit medicines from entering the supply chain. Gufic's adherence to these regulations is essential to maintain and grow its presence in the EU market.

Gufic Biosciences Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gufic's Indore facility, which commenced production in October 2024, is designed to meet WHO GMP, EU GMP, ANVISA, MHRA, and USFDA standards. This facility has achieved 30% capacity utilization for FY26 and is on track for EBITDA breakeven. Such compliance not only facilitates market access but also enhances the company's reputation for quality and reliability. (scanx.trade)

However, recent tax-related penalties highlight the importance of robust internal controls and adherence to financial regulations. Gufic's proactive approach in appealing these penalties demonstrates its commitment to regulatory compliance and financial integrity.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Teicoplanin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Gufic Biosciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 87 individual customs records matching Gufic Biosciences Limited exporting Teicoplanin, covering 68 formulations to 8 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 44+ countries, 108+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Teicoplanin

Teicoplanin

Gufic Biosciences Limited — Teicoplanin Exporter Profile

Gufic Biosciences Limited — Teicoplanin Export Profile: Buyers & Destinations

Where Does Gufic Biosciences Limited Export Teicoplanin?

Who Are the Top Buyers of Teicoplanin from Gufic Biosciences Limited?

What Is India's Total Teicoplanin Export Value and How Much Does Gufic Biosciences Limited Contribute?

What Is the Average Shipment Value for Gufic Biosciences Limited's Teicoplanin Exports?

How Does Gufic Biosciences Limited Compare to Other Indian Teicoplanin Exporters?

What Teicoplanin Formulations Does Gufic Biosciences Limited Export?

Regulatory Requirements: Exporting Teicoplanin to Key Markets

South Africa — SAHPRA

How Does Gufic Biosciences Limited Compare to Nearest Teicoplanin Exporters?

Which Indian Ports Ship Teicoplanin Exports?

What Other Advanced Antibiotics Products Does Gufic Biosciences Limited Export?

Geopolitical & Trade Policy Impact on Gufic Biosciences Limited's Teicoplanin Exports

Gufic Biosciences Limited — Regulatory Compliance & Quality Standards

About Gufic Biosciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Teicoplanin Export Data from Gufic Biosciences Limited

Teicoplanin Stats

Company Overview

Top Products by Gufic Biosciences Limited

Related Analysis

Need Detailed Export Data?

Data Source